EricRudolphMortensenMD

PubMed

• A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.
  Hunt RH, Bowen B, Mortensen ER, Simon TJ, James C, Cagliola A, Quan H, Bolognese JA> ;The American journal of medicine.
• 160 citations
  Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
  Kevin L. Winthrop, Sung Hwan Park, Ahmet Gül, Mario H. Cardiel, Juan J. Gomez-Reino, Yoshiya Tanaka, Kenneth Kwok, Tatjana Lukic, E. Mortensen, D. Ponce de Leon, R. Ri...> ;Annals of the Rheumatic Diseases. 2016 Jun 1
• 248 citations
  Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
  Kevin L. Winthrop, Hisashi Yamanaka, Hernan Valdez, Eric Mortensen, Robert Chew, Sriram Krishnaswami, Thomas T. Kawabata, R. Riese> ;Arthritis & Rheumatology. 2014 Oct 1
• A randomized, placebo-controlled phase 3 trial (study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
  Irving, G., Pénzes, J., Ramjattan, B., Cousins, M., Rauck, R., Spierings, E. L., Kleoudis, C. S., Snidow, J. W., Pierce, A., Wurzelmann, J., Mortensen, E. R.> ;J Pain. 2011 Feb
• A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
  Jansen, J., Lorch, D., Langan, J., Lasko, B., Hermanns, K., Kleoudis, C.S., Snidow, J.W., Pierce, A., Wurzelmann, J., Mortensen, E.R.> ;J Pain. 2011 Feb
• 262 citations
  Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized...
  Christopher J. Hawkey, Loren Laine, Thomas J. Simon, Andre Beaulieu, José A. Maldonado-Cocco, Eduardo Acevedo, Aditi Shahane, Hui Quan, James A. Bolognese, Eric Mortensen> ;Arthritis and Rheumatism. 2000 Feb 1
• Join now to see all